Search hospitals > Massachusetts > Springfield
Baystate Medical Center
Claim this profileSpringfield, Massachusetts 01199
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Ovarian Cancer
Conducts research for Lung Cancer
Conducts research for Breast Cancer
446 reported clinical trials
25 medical researchers
Summary
Baystate Medical Center is a medical facility located in Springfield, Massachusetts. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Ovarian Cancer, Lung Cancer, Breast Cancer and other specialties. Baystate Medical Center is involved with conducting 446 clinical trials across 730 conditions. There are 25 research doctors associated with this hospital, such as Tashanna Myers, John C. McCann, Joanna G. Luty, and Amir Lotfi, MD.Top PIs
Tashanna MyersBaystate Medical Center5 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
20 reported clinical trials
57 drugs studied
John C. McCannBaystate Medical Center2 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
40 drugs studied
Joanna G. LutyBaystate Medical Center6 years of reported clinical research
Studies Cancer
Studies Neuroblastoma
9 reported clinical trials
34 drugs studied
Amir Lotfi, MDBaystate Medical Center3 years of reported clinical research
Studies Myocardial Infarction
Studies Heart Attack
4 reported clinical trials
8 drugs studied
Clinical Trials running at Baystate Medical Center
Ovarian Cancer
Lung Cancer
Stroke
Endometrial Cancer
Cancer
Breast Cancer
Testicular cancer
Atrial Fibrillation
Uterine Cancer
Non-Small Cell Lung Cancer
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting2 awards Phase 34 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Baystate Medical Center?
Baystate Medical Center is a medical facility located in Springfield, Massachusetts. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Ovarian Cancer, Lung Cancer, Breast Cancer and other specialties. Baystate Medical Center is involved with conducting 446 clinical trials across 730 conditions. There are 25 research doctors associated with this hospital, such as Tashanna Myers, John C. McCann, Joanna G. Luty, and Amir Lotfi, MD.
Where is Baystate Medical Center located?
**Directions to Baystate Medical Center, Springfield, MA:**
- For Baystate Medical Center, located in Springfield, Massachusetts, take I-91 Northbound and exit at Main Street. Continue towards Springfield/Chestnut Streets.
- Alternatively, for direct navigation to the Chestnut or Wesson Buildings, set your GPS to "695 Chestnut Street".
Who should I call to ask about financial aid or insurance network?
For insurance-related inquiries at Baystate Medical Center, contact Patient Billing Services at 413-794-9999 or 877-461-1931 for information on accepted insurances, deductibles, coinsurance, copayments, and financial assistance policies. For specific questions about financial assistance, reach out to the Financial Assistance Department at 413-794-2452.
What insurance does Baystate Medical Center accept?
Baystate Medical Center accepts a wide range of insurance plans, including Aetna, Beacon Health Options, Blue Cross / Blue Shield of Massachusetts, BMC HealthNet, Celticare Insurance, and Health New England. For specific inquiries about insurance acceptance, contact Patient Billing at 413-794-9999. Additionally, Baystate Health Advantage Medical Plan and HSA Medical Plan Members can access a directory for information on providers within the Health New England network participating in the Baystate and Baycare Tier 1 network.
What awards or recognition has Baystate Medical Center received?
Baystate Medical Center, located in Springfield, Massachusetts, is a leader in nursing excellence and quality patient outcomes, having earned the Magnet® designation from the American Nurses Credentialing Center (ANCC) four times consecutively. The hospital has also been awarded the Paul Coverdell Stroke – Systems of Care Collaboration Award four times, with the second recognition at the Gold level, for its commitment to improving patient outcomes in alignment with AACN’s standards.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.